- Infection prevention is an enterprise risk boards can’t delegate away
- UT Health San Antonio launches workforce program with $6.5M gift
- New York system medical chief to exit role
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Penn Medicine Lancaster General Health taps associate COO
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Scaling DSOs: Why Integration & Liquidity Planning Matter Now
- Elizabeth Holmes’ prison sentence trimmed by 1 year
- Tennessee physician practice acquired
- HCA Florida unveils air ambulance service for rural communities
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Adventist Health sees momentum from insourcing revenue cycle operations
- 19 women making moves in healthcare
- Beyond coverage: Why health systems must reframe anesthesia as an enterprise operating model
- Indiana Orthopedic Institute to open outpatient clinic
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Inside Surgery Partners’ 5-year strategy pivot
- Inside Rothman Orthopaedics’ physician growth
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- Medical Clinic of Houston adds Dr. Jordan Shapiro
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- The worst states for physicians in the last 5 years
- West Virginia hospital to end OB delivery services
- Dr. Kevin Liu named interim GI chief at the University of Arizona
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- 4 health systems outsourcing RCM functions
- Mayo Clinic receives $75M gift for logistics hub project
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- EP ablation in the ASC: Opportunity meets operational reality
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- What You Do While Sitting Could Predict Dementia Risk
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- The hospitals, health systems cutting jobs in 2026
- Nonprofit highlights rural opioid care strategies
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Providence narrows operating loss to $486M in 2025
- What the Health? From KFF Health News: A Headless CDC
- Rhode Island oral surgeon launches Congressional campaign
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- Oklahoma House passes bill expanding scope of dental assistants
- California behavioral health agency to close 2 centers
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
Safe, or not safe?
The moral, scientific, and financial debate continues at both state and federal levels.
Iowa lawmakers target abortion pills with bill limiting mail orders
Brianne Pfannenstiel | Feb. 9, 2026
Iowa lawmakers are targeting medications that induce abortions with legislation that would require patients to see a doctor in person to gain access to the drug.
Senate Study Bill 3115 would require physicians to examine a patient and administer abortion medications in person, while also informing patients about the possibility of abortion reversals — a concept that medical professionals say science doesn't support.
The legislation also requires providers to begin compiling information for the state when women face complications caused by medication abortions.
The bill appears aimed at limiting the telehealth and mail-order prescriptions of drugs such as mifepristone, which have come under intense scrutiny by anti-abortion advocates and lawmakers across the country.
The country has seen a rise in people seeking abortions through telehealth after the U.S. Supreme Court overturned Roe v. Wade in 2022 and some states were able to enact sweeping abortion bans.
Sen. Jason Schultz, R-Schleswig, who led a Feb. 9 subcommittee on the bill, said the goal of the legislation is to crack down on abortion pills sold without medical oversight and ensure patients receive “informed consent” about possible side effects of the medications.
“I can't get past the idea that we're dealing with a black market, unprescribed pharmaceuticals,” Schultz said.
The Food and Drug Administration has approved the use of the abortion pill mifepristone, determining it is safe and effective if used as directed.
Sen. Janice Weiner, D-Iowa City, also served on the subcommittee. She said the bill continues to limit access to abortion, even after Iowa enacted a six-week ban on the procedure.
“Women all across this state have now had enough time since the six-week ban went into effect to understand what they've lost: basic health care, the ability for an OB to make split-second decisions, the right to determine their own futures and decide when and how to have a family,” she said. “To me, this isn't about safety. It's about making it even harder for women in Iowa to get health care.”
The three-person subcommittee voted to advance the legislation to a full committee.
Medical advocates say ‘abortion reversals’ aren’t supported by science
Medical advocates pushed back on the proposal, saying the legislation would require them to share misinformation with their patients.
According to the American College of Obstetricians & Gynecologists, medication abortion reversals are not supported by science.
“This bill will force physicians to offer information that is not evidence-based and conflicts with accepted medical standards,” said Francesca Turner, a physician and the legislative co-chair of the Iowa chapter of ACOG.
The bill also allows women or their family members to sue doctors who violate the law.
Seth Brown, a lobbyist for the Iowa Medical Society, said doctors will be required to follow the law, but he worries that requiring them to share medical advice that is not backed by scientific study would open them up to medical malpractice lawsuits.
“So it's a bit of a lose-lose from the physician's standpoint,” he said.
Schultz said that is a concern and “a very real consideration” as the Legislature continues to debate the bill. He promised the next iteration up for discussion by legislators would include amendments.
Anti-abortion advocates cheer proposal
Tom Chapman, director of the Iowa Catholic Conference, spoke in favor of the change.
“Obviously, our group doesn't support abortion,” he said. “But it seems best for women to see a medical professional before taking these pills. In our view, it doesn't interfere with the doctor-patient relationship. It actually requires one.”
Some anti-abortion groups said they wished it went further.
“While we would support taking this drug completely off the market, in the meantime, we want some commonsense safeguards to ensure the safety of women who are ingesting this drug,” said Maggie DeWitte, executive director of Pulse Life Advocates.
She said women are often “alone and traumatized” when they seek abortions, and she cheered the portions of the bill she said prioritized “informed consent” for patients.
“This bill would require physicians to provide information regarding the risks and complications that can occur when taking this drug,” she said.
Protesters advocate for bill that would criminalize abortions
While the subcommittee meeting took place, a group of more than a hundred people from a pair of anti-abortion groups, Abolitionists Rising and Iowa Abolitionists, gathered a floor below in the Capitol rotunda where they prayed, sang and advocated for a total ban on abortion in Iowa.
Sam Jones, one of the event's organizers and a pastor at Abundant Life Christian Fellowship Church in Humboldt, said the group's goal is "the total and immediate abolishing of abortion."
"‘Abolish abortion’ means that we would treat abortion as murder and we would have it just the same as all murder laws," he said. "So from the moment of conception all the way through it would be treated just the same as killing another human being."
Jones said the group believes Iowa's current abortion laws are insufficient because there are no criminal penalties for doctors who perform abortions in Iowa or the women who receive them.
They support House File 2316, a bill sponsored by Rep. Zach Dieken, R-Granville, and seven other Republicans. That bill would classify any abortion as a homicide, with exceptions for miscarriages and procedures performed to save the life of the mother.
Some members of the group held signs comparing abortion to slavery, murder and child sacrifice. Others held signs that read "equal justice" and advocated for House File 2316.
Schultz declined to comment on the issue.
“That is something totally unrelated to our subcommittee,” he told reporters. “And I don't have anything to say about that.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















